Validus Holdings, Ltd. (VR) Shares Sold by Northern Trust Corp

Northern Trust Corp cut its position in Validus Holdings, Ltd. (NYSE:VR) by 1.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 664,881 shares of the insurance provider’s stock after selling 8,012 shares during the period. Northern Trust Corp’s holdings in Validus were worth $44,846,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of VR. Schwab Charles Investment Management Inc. boosted its stake in shares of Validus by 7.5% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 412,351 shares of the insurance provider’s stock worth $19,348,000 after acquiring an additional 28,787 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Validus by 48.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,315 shares of the insurance provider’s stock worth $202,000 after buying an additional 1,410 shares during the last quarter. American Century Companies Inc. boosted its stake in Validus by 6.4% during the fourth quarter. American Century Companies Inc. now owns 807,454 shares of the insurance provider’s stock worth $37,886,000 after buying an additional 48,365 shares during the last quarter. Teacher Retirement System of Texas boosted its stake in Validus by 323.6% during the fourth quarter. Teacher Retirement System of Texas now owns 27,706 shares of the insurance provider’s stock worth $1,300,000 after buying an additional 21,165 shares during the last quarter. Finally, Swiss National Bank boosted its stake in Validus by 2.5% during the fourth quarter. Swiss National Bank now owns 135,500 shares of the insurance provider’s stock worth $6,358,000 after buying an additional 3,300 shares during the last quarter. 81.90% of the stock is currently owned by hedge funds and other institutional investors.

In other Validus news, President Kean Driscoll sold 6,875 shares of Validus stock in a transaction on Tuesday, May 15th. The stock was sold at an average price of $67.29, for a total value of $462,618.75. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders sold 20,625 shares of company stock worth $1,391,363 in the last 90 days. Company insiders own 2.33% of the company’s stock.

NYSE VR opened at $67.88 on Wednesday. The firm has a market cap of $5.38 billion, a price-to-earnings ratio of -63.44, a P/E/G ratio of 1.83 and a beta of 1.01. The company has a current ratio of 0.97, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. Validus Holdings, Ltd. has a fifty-two week low of $41.15 and a fifty-two week high of $67.96.

Validus (NYSE:VR) last posted its earnings results on Tuesday, May 1st. The insurance provider reported $0.53 EPS for the quarter, missing the Zacks’ consensus estimate of $1.09 by ($0.56). Validus had a negative net margin of 5.06% and a negative return on equity of 2.69%. The business had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter in the prior year, the firm earned $0.95 EPS. Validus’s revenue for the quarter was up 46.9% compared to the same quarter last year. equities analysts anticipate that Validus Holdings, Ltd. will post 4.12 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 30th. Shareholders of record on Tuesday, May 15th were given a $0.38 dividend. The ex-dividend date was Monday, May 14th. This represents a $1.52 dividend on an annualized basis and a yield of 2.24%. Validus’s dividend payout ratio is currently -142.06%.

VR has been the topic of a number of recent research reports. Buckingham Research lowered Validus from a “buy” rating to a “neutral” rating in a research note on Tuesday, February 13th. Zacks Investment Research lowered Validus from a “buy” rating to a “hold” rating in a research note on Wednesday, May 9th. Finally, ValuEngine raised Validus from a “hold” rating to a “buy” rating in a research note on Saturday, June 2nd. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $51.25.

Validus Company Profile

Validus Holdings, Ltd. provides reinsurance coverage, insurance coverage, and insurance linked securities management services worldwide. It operates through three segments: Reinsurance, Insurance, and Asset Management. The Reinsurance segment underwrites property reinsurance products on a catastrophe excess of loss, per risk excess of loss and proportional basis; and aerospace and aviation, agriculture, composite, marine, technical lines, terrorism, trade credit, workers' compensation, and other specialty lines, as well as casualty and financial lines.

Want to see what other hedge funds are holding VR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Validus Holdings, Ltd. (NYSE:VR).

Institutional Ownership by Quarter for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit